• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

消除麻疹:确定易感亚人群,制定免疫策略。

Measles Elimination: Identifying Susceptible Sub-Populations to Tailor Immunization Strategies.

机构信息

Department of Hygiene, Medical Microbiology and Public Health, Medical University Innsbruck, 6020 Innsbruck, Tyrol, Austria.

Department of Pneumology, Regional Hospital Hochzirl-Natters, 6161 Natters, Tirol, Austria.

出版信息

Viruses. 2019 Aug 20;11(8):765. doi: 10.3390/v11080765.

DOI:10.3390/v11080765
PMID:31434243
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6723762/
Abstract

Measles elimination has been identified as a public health priority in Europe for a long time but has not yet been achieved. The World Health Organization (WHO) recommends identification of susceptible sub-populations to target supplementary immunization activities. We used three different sources of information: retrospective samples investigated for measles IgG between 1997 and 2016, vaccine coverage data from the existing electronic registry for birth cohorts 2015 to 1999, and surveillance data from 2009 until 20 July 2019. We calculated susceptibility by birth cohort using seroprevalence data, adjusting vaccine coverage data with reported effectiveness (93% for the first and 97% for the second dose, respectively), and compared it with measles incidence data, aggregated by birth cohorts and districts. Susceptibility levels for persons 10-41 years (birth cohorts 2007-1976) were 10.4% and thus far above the recommended values of WHO (5%). Older birth cohorts were sufficiently protected. Districts with the highest susceptibility estimates corresponded with districts with the highest incidence rates. Birth cohorts with susceptibility levels > 10% showed a 4.7 increased relative risk of having had more than one measles case. We conclude that retrospective serosurveys are a cheap and useful approach in identifying susceptible sub-populations, especially for older birth cohorts whose coverage data remain scarce.

摘要

消除麻疹在欧洲一直被视为公共卫生重点,但尚未实现。世界卫生组织(WHO)建议确定易感染亚人群,以针对补充免疫活动。我们使用了三种不同的信息来源:1997 年至 2016 年间调查麻疹 IgG 的回顾性样本、2015 年至 1999 年出生队列的现有电子登记册中的疫苗覆盖率数据,以及 2009 年至 2019 年 7 月 20 日的监测数据。我们使用血清流行率数据按出生队列计算易感性,用报告的有效性(第一剂为 93%,第二剂为 97%)调整疫苗覆盖率数据,并将其与按出生队列和地区汇总的麻疹发病率数据进行比较。10-41 岁(2007-1976 年出生队列)人群的易感性水平为 10.4%,远高于世界卫生组织(WHO)推荐的 5%。较年长的出生队列得到了充分保护。易感性估计值最高的地区与发病率最高的地区相对应。易感性水平>10%的出生队列发生麻疹病例超过一次的相对风险增加了 4.7 倍。我们得出结论,回顾性血清学调查是识别易感染亚人群的一种廉价且有用的方法,尤其是对于疫苗覆盖率数据仍然稀缺的较年长的出生队列。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e1/6723762/a712fc1e7685/viruses-11-00765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e1/6723762/629a3aa93c5f/viruses-11-00765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e1/6723762/21d716512d31/viruses-11-00765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e1/6723762/a712fc1e7685/viruses-11-00765-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e1/6723762/629a3aa93c5f/viruses-11-00765-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e1/6723762/21d716512d31/viruses-11-00765-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a7e1/6723762/a712fc1e7685/viruses-11-00765-g003.jpg

相似文献

1
Measles Elimination: Identifying Susceptible Sub-Populations to Tailor Immunization Strategies.消除麻疹:确定易感亚人群,制定免疫策略。
Viruses. 2019 Aug 20;11(8):765. doi: 10.3390/v11080765.
2
Progress Toward Measles Elimination - European Region, 2009-2018.迈向消除麻疹的进展 - 欧洲区域,2009-2018 年。
MMWR Morb Mortal Wkly Rep. 2019 May 3;68(17):396-401. doi: 10.15585/mmwr.mm6817a4.
3
Seroprevalence of measles among children affected by national measles elimination program in Korea, 2010.2010 年韩国全国麻疹消除计划中受影响儿童麻疹血清流行率。
Vaccine. 2012 May 14;30(23):3355-9. doi: 10.1016/j.vaccine.2012.03.073. Epub 2012 Apr 5.
4
[Vaccination coverage against measles and sero-epidemiology of measles-specific IgG antibodies in German children and adolescents].[德国儿童和青少年的麻疹疫苗接种覆盖率及麻疹特异性IgG抗体的血清流行病学]
Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2013 Sep;56(9):1243-52. doi: 10.1007/s00103-013-1790-6.
5
Predicting and comparing long-term measles antibody profiles of different immunization policies.预测和比较不同免疫策略的长期麻疹抗体谱。
Bull World Health Organ. 2001;79(7):615-24.
6
National serologic survey of measles immunity among persons 6 years of age or older, 1988-1994.1988 - 1994年6岁及以上人群麻疹免疫状况的全国血清学调查
MedGenMed. 2001 Jan 24:E5.
7
Progress towards measles elimination in Singapore.新加坡在消除麻疹方面取得的进展。
Vaccine. 2014 Dec 5;32(51):6927-6933. doi: 10.1016/j.vaccine.2014.10.046. Epub 2014 Nov 4.
8
Comparative Estimates of Crude and Effective Coverage of Measles Immunization in Low-Resource Settings: Findings from Salud Mesoamérica 2015.低资源环境下麻疹免疫接种的粗覆盖率和有效覆盖率的比较估计:来自2015年中美洲健康计划的结果
PLoS One. 2015 Jul 2;10(7):e0130697. doi: 10.1371/journal.pone.0130697. eCollection 2015.
9
Measles epidemics and seroepidemiology of population in Wujin, Changzhou city, Jiangsu province, China 2015.2015年中国江苏省常州市武进区麻疹疫情及人群血清流行病学调查
Vaccine. 2017 May 19;35(22):2925-2929. doi: 10.1016/j.vaccine.2017.04.018. Epub 2017 Apr 19.
10
Progress Toward Measles Elimination - Bangladesh, 2000-2016.2000 - 2016年孟加拉国在消除麻疹方面取得的进展
MMWR Morb Mortal Wkly Rep. 2017 Jul 21;66(28):753-757. doi: 10.15585/mmwr.mm6628a3.

引用本文的文献

1
The Unprotected: Measles Seroprevalence in Children During the First Two Years of Life.未受保护者:一岁至两岁儿童的麻疹血清阳性率
Viruses. 2025 Jul 11;17(7):973. doi: 10.3390/v17070973.
2
Seroprevalence against measles, Austria, stratified by birth years 1922 to 2024.奥地利按1922年至2024年出生年份分层的麻疹血清流行率。
Euro Surveill. 2025 Apr;30(16). doi: 10.2807/1560-7917.ES.2025.30.16.2400684.
3
An Upsurge of Measles Cases in Mali-a Consequence of Pandemic-associated Disruption in Routine Immunization.马里麻疹病例激增——常规免疫接种因疫情受到干扰的后果

本文引用的文献

1
Comparison of antibody response between boys and girls after infant and childhood vaccinations in the Netherlands.荷兰婴幼儿及儿童期疫苗接种后男童和女童抗体反应比较。
Vaccine. 2019 Jul 26;37(32):4504-4510. doi: 10.1016/j.vaccine.2019.06.055. Epub 2019 Jul 4.
2
Progress Toward Measles Elimination - European Region, 2009-2018.迈向消除麻疹的进展 - 欧洲区域,2009-2018 年。
MMWR Morb Mortal Wkly Rep. 2019 May 3;68(17):396-401. doi: 10.15585/mmwr.mm6817a4.
3
Towards equity in immunisation.迈向公平免疫。
Open Forum Infect Dis. 2024 Mar 19;11(4):ofae154. doi: 10.1093/ofid/ofae154. eCollection 2024 Apr.
4
Seroprevalence of Measles-, Mumps-, and Rubella-specific antibodies in the German adult population - cross-sectional analysis of the German Health Interview and Examination Survey for Adults (DEGS1).德国成年人群中麻疹、腮腺炎和风疹特异性抗体的血清流行率——德国成年人健康访谈与检查调查(DEGS1)的横断面分析
Lancet Reg Health Eur. 2021 Jun 5;7:100128. doi: 10.1016/j.lanepe.2021.100128. eCollection 2021 Aug.
5
Morbilliviruses: Entry, Exit and Everything In-Between.麻疹病毒:进入、退出及其间的一切。
Viruses. 2019 Nov 7;11(11):1036. doi: 10.3390/v11111036.
Euro Surveill. 2019 Jan;24(2). doi: 10.2807/1560-7917.ES.2019.24.2.1800204.
4
Utilization and impact of European immunization week to increase measles, mumps, rubella vaccine uptake in Austria in 2016.2016年欧洲免疫周在奥地利提高麻疹、腮腺炎、风疹疫苗接种率方面的应用及影响
Vaccine. 2017 Sep 5;35(37):4836-4839. doi: 10.1016/j.vaccine.2017.07.047. Epub 2017 Aug 7.
5
An assessment of measles vaccine effectiveness, Australia, 2006-2012.2006 - 2012年澳大利亚麻疹疫苗有效性评估
Western Pac Surveill Response J. 2015 Jul 9;6(3):43-50. doi: 10.5365/WPSAR.2015.6.2.007. eCollection 2015 Jul-Sep.
6
Self-collected buccal swabs and rapid, real-time PCR during a large measles outbreak in Wales: Evidence for the protective effect of prior MMR immunisation.在威尔士大规模麻疹疫情期间的自我采集口腔拭子及快速实时聚合酶链反应:既往麻疹、腮腺炎、风疹联合疫苗免疫保护作用的证据
J Clin Virol. 2015 Jun;67:1-7. doi: 10.1016/j.jcv.2015.03.012. Epub 2015 Mar 17.
7
Impact of measles national vaccination coverage on burden of measles across 29 Member States of the European Union and European Economic Area, 2006-2011.2006-2011 年麻疹国家免疫接种覆盖率对 29 个欧盟和欧洲经济区成员国麻疹负担的影响。
Vaccine. 2014 Apr 1;32(16):1814-9. doi: 10.1016/j.vaccine.2014.01.094. Epub 2014 Feb 13.
8
Measles vaccination before the measles-mumps-rubella vaccine.麻腮风疫苗前接种麻疹疫苗。
Am J Public Health. 2013 Aug;103(8):1393-401. doi: 10.2105/AJPH.2012.301075. Epub 2013 Jun 13.
9
Measles still spreads in Europe: who is responsible for the failure to vaccinate?麻疹在欧洲仍有传播:谁应为未能接种疫苗负责?
Clin Microbiol Infect. 2012 Oct;18 Suppl 5:50-6. doi: 10.1111/j.1469-0691.2012.03982.x. Epub 2012 Aug 27.
10
Mumps outbreak in young adults following a festival in Austria, 2006.2006年奥地利一场节日活动后,年轻成年人中爆发腮腺炎疫情。
Euro Surveill. 2008 Feb 14;13(7):8042. doi: 10.2807/ese.13.07.08042-en.